Torsten Herbertz

Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery

Arup K. Ghose, Torsten Herbertz, Robert L. Hudkins et al. · ACS Chemical Neuroscience · 2011 · 432 citations · Full text

Cns Drug Discovery, Pharmaceutical Research, Drug Target +18

VP1 Sequencing of All Human Rhinovirus Serotypes:Insights into Genus Phylogeny and Susceptibility to AntiviralCapsid-BindingCompounds

Rebecca M. Ledford, Nitesh R. Patel, Tina M. Demenczuk et al. · Journal of Virology · 2004 · 209 citations · Full text

Virus Susceptibility, Viral Evolution, Molecular Virology +13

Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E

Martin W. Rowbottom, Raffaella Faraoni, Qi Chao et al. · Journal of Medicinal Chemistry · 2011 · 58 citations · Full text

Orally Efficacious Inhibitor, Chemoprevention Strategy, Immunology +19

The discovery and structure–activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase

Matthew G. LaPorte, Tandy L. Draper, Lori E. Miller et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 34 citations

Medicinal Chemistry, Biochemistry, Viral Polymerase Structure +9

Electron Transfer Photochemistry of Chrysanthemol:  An Intramolecular S_N2‘ Reaction of a Vinylcyclopropane Radical Cation

Torsten Herbertz, Heinz D. Roth · Journal of the American Chemical Society · 1996 · 33 citations